Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...
During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...
Johnson & Johnson has secured European approval for the subcutaneous formulation of Darzalex, combined with bortezomib, lenalidomide, and dexamethasone, for newly diagnosed multiple myeloma patients ...
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant ...
Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ...
That extends the use of the drug in relapsed or refractory disease – for which it has been FDA-approved since 2020 – and makes it the first anti-CD38 competition to Darzalex (daratumumab ...
J&J reported overall revenues up 4.3% to $22.4 billion in the second quarter, fuelled by growth for blood cancer therapy Darzalex (daratumumab) and particularly subcutaneous version Darzalex ...
In separate, live virtual events, Doris Hansen, MD, and Leyla O. Shune, MD, discuss options for a patient with ...
The change negotiations that started on 4 September 2024 covered approximately 220 people. At the beginning of the negotiations, the planned measures were estimated to lead to the termination of up to ...
Israel struck military bases but avoided targeting nuclear facilities. Iran has so far largely played down the attack, but now faces a decision about how to respond. Paramilitary forces ransacked ...
At a meeting of emerging economies, Vladimir Putin positioned himself as a respected and powerful leader, ignoring the condemnation he receives from the West. By David Pierson and Valerie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback